Mengis Capital Management Inc decreased its stake in Qualcomm Inc Com (QCOM) by 44.1% based on its latest 2019Q2 regulatory filing with the SEC. Mengis Capital Management Inc sold 49,427 shares as the company’s stock declined 15.29% . The institutional investor held 62,657 shares of the radio and television broadcasting and communications equipment company at the end of 2019Q2, valued at $4.77M, down from 112,084 at the end of the previous reported quarter. Mengis Capital Management Inc who had been investing in Qualcomm Inc Com for a number of months, seems to be less bullish one the $95.32 billion market cap company. The stock decreased 0.85% or $0.67 during the last trading session, reaching $78.41. About 1.57 million shares traded. QUALCOMM Incorporated (NASDAQ:QCOM) has risen 17.92% since September 14, 2018 and is uptrending. It has outperformed by 17.92% the S&P500. Some Historical QCOM News: 16/04/2018 – Martin Soong: Qualcomm to refile China antitrust application for $44 billion NXP takeover; 06/03/2018 – Qualcomm’s Spending Buys the Right Friends; 05/03/2018 – Broadcom Reiterates Qualcomm Did Not Inform Its Own Stockholders or Broadcom of Its Secret, Voluntary Unilateral Request Filed on Jan 29, 2018; 13/03/2018 – In U.S.-China Tech Rivalry, Whose Side Is Qualcomm On?; 13/03/2018 – QUALCOMM: BROADCOM MUST PERMANENTLY ABANDON ATTEMPT TO BUY QCOM; 19/04/2018 – QUALCOMM & NXP AGREE TO WITHDRAW & REFILE APPLICATION IN CHINA; 16/03/2018 – NEW: Qualcomm board is meeting now and discussing fate of former CEO, chairman and current board member Paul Jacobs, Dow Jones reports; Jacobs indicated interest to Qualcomm’s board about taking the firm private, sources told CNBC; 14/05/2018 – In concession, Trump will help China’s ZTE ‘get back into business’; 16/03/2018 – Qualcomm Director Paul Jacobs will not be re-nominated to board; 18/04/2018 – @JimCramer’s lightning round: Qualcomm needs to resolve its slew of issues
Meeder Asset Management Inc decreased its stake in Seattle Genetics Inc (SGEN) by 99.52% based on its latest 2019Q2 regulatory filing with the SEC. Meeder Asset Management Inc sold 5,342 shares as the company’s stock rose 13.00% . The institutional investor held 26 shares of the health care company at the end of 2019Q2, valued at $2,000, down from 5,368 at the end of the previous reported quarter. Meeder Asset Management Inc who had been investing in Seattle Genetics Inc for a number of months, seems to be less bullish one the $11.42 billion market cap company. The stock decreased 0.35% or $0.25 during the last trading session, reaching $70.63. About 483,288 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 8.86% since September 14, 2018 and is uptrending. It has outperformed by 8.86% the S&P500. Some Historical SGEN News: 17/05/2018 – Seattle Genetics Announces Data Presentations at 2018 ASCO Annual Meeting; 05/04/2018 – Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter Financial Results on April 26, 2018; 09/03/2018 – Seattle Genetics Completes Acquisition Of Cascadian Therapeutics; 26/04/2018 – Seattle Genetics Had Seen 2018 R&D Costs $460M-$500M; 20/03/2018 – SEATTLE GENETICS INC – FDA ALSO GRANTED PRIORITY REVIEW FOR SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR ADCETRIS; 26/04/2018 – SEATTLE GENETICS INC – ECHELON-2 DATA EXPECTED IN 2018; 09/03/2018 – SEATTLE GENETICS: CASCADIAN THERAPEUTICS TENDER OFFER COMPLETE; 16/04/2018 – CELLDEX THERAPEUTICS INC – GLEMBATUMUMAB VEDOTIN SAFETY PROFILE WAS CONSISTENT WITH PRIOR EXPERIENCE; 26/04/2018 – Seattle Genetics 1Q Loss $111.7M; 26/03/2018 – ASTELLAS & SEATTLE GENETICS GET BREAKTHROUGH DESIGNATION FOR EN
More notable recent Seattle Genetics, Inc. (NASDAQ:SGEN) news were published by: Seekingalpha.com which released: “New chief commercial officer at Seattle Genetics – Seeking Alpha” on May 21, 2019, also Finance.Yahoo.com with their article: “The Week Ahead In Biotech: Conference Presentations, IPO News Flow Take The Spotlight – Yahoo Finance” published on September 08, 2019, Seekingalpha.com published: “Seattle Genetics Q3 top line up 25% – Seeking Alpha” on October 25, 2018. More interesting news about Seattle Genetics, Inc. (NASDAQ:SGEN) were released by: Benzinga.com and their article: “10 Biggest Price Target Changes For Thursday – Benzinga” published on September 12, 2019 as well as Nasdaq.com‘s news article titled: “After-Hours Earnings Report for July 16, 2019 : CSX, CTAS, UAL, FNF, SGEN, PNFP, IBKR, HWC, FULT, HOPE, UBNK – Nasdaq” with publication date: July 16, 2019.
Investors sentiment decreased to 0.87 in 2019 Q2. Its down 0.67, from 1.54 in 2019Q1. It dropped, as 30 investors sold SGEN shares while 93 reduced holdings. 27 funds opened positions while 80 raised stakes. 156.77 million shares or 0.53% less from 157.61 million shares in 2019Q1 were reported. The Texas-based Twin Tree Ltd Partnership has invested 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). Next Fincl Group Inc has 0% invested in Seattle Genetics, Inc. (NASDAQ:SGEN). Great Lakes Advsrs Ltd Company has 177,688 shares for 0.27% of their portfolio. Nuveen Asset Mngmt Ltd Limited Liability Company owns 546,315 shares. Landscape Mngmt holds 0.04% or 7,535 shares. Creative Planning holds 16,596 shares. Mirae Asset Global Invests Co Ltd reported 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). Asset Mgmt One Limited invested in 0.04% or 128,999 shares. Employees Retirement Of Ohio owns 38,062 shares. Paloma Ptnrs has invested 0.01% in Seattle Genetics, Inc. (NASDAQ:SGEN). Tradewinds Cap Mgmt Limited Co holds 0.03% or 972 shares. Csat Invest Advisory Ltd Partnership, Michigan-based fund reported 391 shares. 1,500 are owned by Quantbot Techs L P. Swiss Bancshares invested in 0.03% or 366,400 shares. Pictet Asset Management Limited reported 554,163 shares stake.
Analysts await Seattle Genetics, Inc. (NASDAQ:SGEN) to report earnings on October, 24. They expect $-0.37 EPS, down 37.04% or $0.10 from last year’s $-0.27 per share. After $-0.24 actual EPS reported by Seattle Genetics, Inc. for the previous quarter, Wall Street now forecasts 54.17% negative EPS growth.
Meeder Asset Management Inc, which manages about $3.85 billion and $1.43B US Long portfolio, upped its stake in Ishares Msci Eafe Small (SCZ) by 8,965 shares to 27,123 shares, valued at $1.56M in 2019Q2, according to the filing. It also increased its holding in Ally Financial Inc (NYSE:ALLY) by 44,171 shares in the quarter, for a total of 130,196 shares, and has risen its stake in Costco Wholesale Corp (NASDAQ:COST).
Analysts await QUALCOMM Incorporated (NASDAQ:QCOM) to report earnings on November, 6. They expect $0.55 EPS, down 27.63% or $0.21 from last year’s $0.76 per share. QCOM’s profit will be $668.61 million for 35.64 P/E if the $0.55 EPS becomes a reality. After $0.64 actual EPS reported by QUALCOMM Incorporated for the previous quarter, Wall Street now forecasts -14.06% negative EPS growth.
More notable recent QUALCOMM Incorporated (NASDAQ:QCOM) news were published by: Nasdaq.com which released: “Noteworthy Thursday Option Activity: RTN, QCOM, V – Nasdaq” on September 05, 2019, also Nasdaq.com with their article: “Will Lower Revenues Hurt Qualcomm’s (QCOM) Q3 Earnings? – Nasdaq” published on July 29, 2019, Finance.Yahoo.com published: “Morgan Stanley Remains Bullish On Qualcomm, But Sees Uncertainty With China, CFO Search – Yahoo Finance” on August 26, 2019. More interesting news about QUALCOMM Incorporated (NASDAQ:QCOM) were released by: Nasdaq.com and their article: “Notable ETF Inflow Detected – QQQ, TXN, QCOM, MU – Nasdaq” published on August 21, 2019 as well as Nasdaq.com‘s news article titled: “Qualcomm (QCOM) Stock Moves -0.83%: What You Should Know – Nasdaq” with publication date: June 25, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.